tiprankstipranks
Advertisement
Advertisement

XNCR Stock Latest News

Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
The FlyHemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
1d ago
DYN
RNA
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
PremiumThe Fly
Midday Fly By: Estee Lauder in deal talks with Puig, Smithfield reports Q4 beat
21d ago
EL
RL
Microsoft reinstated, Ralph Lauren upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Microsoft reinstated, Ralph Lauren upgraded: Wall Street’s top analyst calls
21d ago
RL
AJG
JPMorgan downgrades Xencor on lack of ‘needle-moving’ catalysts
PremiumThe Fly
JPMorgan downgrades Xencor on lack of ‘needle-moving’ catalysts
21d ago
XNCR
Xencor downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Xencor downgraded to Neutral from Overweight at JPMorgan
21d ago
XNCR
Xencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors
PremiumCompany AnnouncementsXencor’s Lung Cancer Trial Halted: What the Vudalimab Update Means for XNCR Investors
1M ago
XNCR
Xencor, Genentech to End Protein Therapeutics Collaboration
Premium
Company Announcements
Xencor, Genentech to End Protein Therapeutics Collaboration
1M ago
8K
XNCR
Xencor reports receipt of notice of termination of license agreement from Roche
Premium
The Fly
Xencor reports receipt of notice of termination of license agreement from Roche
1M ago
CHRO
XNCR
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
1M ago
AZN
BMY
Xencor: Buy Rating Reaffirmed on Pipeline Momentum Despite Ultomiris Royalty Headwind
PremiumRatings
Xencor: Buy Rating Reaffirmed on Pipeline Momentum Despite Ultomiris Royalty Headwind
1M ago
XNCR
Xencor Updates Outlook Amid Ultomiris Royalty Dispute
PremiumCompany Announcements
Xencor Updates Outlook Amid Ultomiris Royalty Dispute
1M ago
8K
XNCR
Xencor expects cash to fund operations into mid-2028
PremiumThe Fly
Xencor expects cash to fund operations into mid-2028
1M ago
XNCR
3 Best Stocks to Buy Today, 2/26/2026, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Today, 2/26/2026, According to Top Analysts
2M ago
ADTN
LIFE
Xencor price target raised to $27 from $26 at Barclays
Premium
The Fly
Xencor price target raised to $27 from $26 at Barclays
2M ago
XNCR
Buy Rating on Xencor: Advancing T-Cell Engagers and Diversified Pipeline Support Favorable Risk‑Reward
Premium
Ratings
Buy Rating on Xencor: Advancing T-Cell Engagers and Diversified Pipeline Support Favorable Risk‑Reward
2M ago
XNCR
Xencor files automatic mixed securities shelf
PremiumThe Fly
Xencor files automatic mixed securities shelf
2M ago
XNCR
Xencor reports Q4 EPS (9c), consensus (58c)
PremiumThe Fly
Xencor reports Q4 EPS (9c), consensus (58c)
2M ago
XNCR
Xencor price target raised to $20 from $17 at BofA
PremiumThe Fly
Xencor price target raised to $20 from $17 at BofA
3M ago
XNCR
Xencor price target raised to $26 from $23 at Barclays
PremiumThe Fly
Xencor price target raised to $26 from $23 at Barclays
4M ago
XNCR
Xencor’s New Study on XmAb657: A Potential Game-Changer for Muscle Diseases
PremiumCompany AnnouncementsXencor’s New Study on XmAb657: A Potential Game-Changer for Muscle Diseases
4M ago
XNCR
Xencor issued U.S. patent for Xtend Fc domain
Premium
The Fly
Xencor issued U.S. patent for Xtend Fc domain
4M ago
XNCR
Xencor initiated with a Buy at Truist
Premium
The Fly
Xencor initiated with a Buy at Truist
5M ago
XNCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >